B I Kuznik Selected Research

thymogen

1/2020

[Age features of bioregulatory therapy of dental diseases.]

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B I Kuznik Research Topics

Disease

4	Atherosclerosis 01/2019 - 01/2011
4	Thrombosis (Thrombus) 01/2015 - 04/2002
3	COVID-19 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 01/2013
2	Hypertension (High Blood Pressure) 01/2015 - 01/2012
2	Inflammation (Inflammations) 01/2014 - 01/2012
2	Myocardial Infarction 01/2012 - 01/2011
1	Coronavirus Infections 01/2021
1	Pathologic Processes 01/2020
1	Multiple Organ Failure (MODS) 01/2020
1	Stomatognathic Diseases (Dental Disease) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Leiomyoma (Uterine Fibroids) 01/2020
1	Infections 01/2020
1	Hepatitis 01/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Atopic Dermatitis (Atopic Eczema) 04/2016
1	Hypertrophy 01/2016
1	Stroke (Strokes) 01/2015
1	Immune System Diseases (Immune Disorders) 01/2014
1	Periodontitis 01/2014
1	Periodontal Diseases (Periodontal Disease) 01/2014
1	Crush Syndrome 01/2013
1	Carcinogenesis 01/2012
1	Lung Abscess 01/2012
1	Cardiac Arrhythmias (Arrythmia) 01/2012
1	Appendicitis 01/2012
1	Ischemic Stroke 01/2011
1	Spontaneous Platelet Aggregation 01/2009
1	Pneumonia (Pneumonitis) 01/2009
1	Diabetes Mellitus 01/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2006
1	Disseminated Intravascular Coagulation 01/2000
1	Burns 01/2000

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 01/2021 - 01/2012
4	thymalinIBA 01/2022 - 01/2000
4	CytokinesIBA 01/2020 - 01/2000
3	lysylglutamic acidIBA 01/2020 - 01/2006
2	AntibodiesIBA 01/2020 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 04/2016 - 01/2014
2	Immunoglobulin G (IgG)IBA 01/2014 - 01/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2012 - 01/2011
1	tocilizumab (atlizumab)FDA Link 01/2022
1	thymogenIBA 01/2020
1	TransferasesIBA 01/2020
1	cortexinIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Quinine (Quinson)FDA Link 01/2020
1	epithalaminIBA 01/2020
1	remdesivirIBA 01/2020
1	InflammasomesIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	ChemokinesIBA 01/2020
1	SigumirIBA 01/2020
1	AntioxidantsIBA 01/2020
1	KininsIBA 01/2019
1	Kallikreins (Kallikrein)IBA 01/2019
1	DefensinsIBA 04/2016
1	Interleukin-10 (Interleukin 10)IBA 04/2016
1	Immunoglobulin E (IgE)IBA 04/2016
1	InterleukinsIBA 04/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	HMGB1 Protein (HMG1)IBA 01/2014
1	AutoantibodiesIBA 01/2014
1	Thrombin FDA Link 01/2013
1	Hemostatics (Antihemorrhagics)IBA 01/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2013
1	Posterior Pituitary HormonesIBA 01/2012
1	ChloridesIBA 01/2012
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 01/2012
1	CalciumIBA 01/2012
1	Immunoglobulin A (IgA)IBA 01/2009
1	Immunoglobulin M (IgM)IBA 01/2009
1	Adenosine Diphosphate (ADP)IBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Antithrombin IIIIBA 01/2006
1	Protein CIBA 01/2006
1	fibrinmonomerIBA 01/2006
1	Interleukin-1 (Interleukin 1)IBA 04/2002
1	Immunologic Factors (Immunomodulators)IBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
1	Injections 01/2013
1	Aftercare (After-Treatment) 01/2012